Published in Vaccine Weekly, November 9th, 2005
The company expects to continue to deliver shipments of FLUVIRIN vaccine throughout October and November and into December.
Chiron has received all necessary approvals from the U.S. Food & Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to start supplying FLUVIRIN vaccine to the U.S. market. Continued shipments of FLUVIRIN vaccine will undergo corresponding internal release procedures and standard FDA influenza...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly